ADC Therapeutics shares are trading higher after Guggenheim initiated coverage on the stock with a Buy rating and announced a price target of $11.

ADC Therapeutics SA -3.55%

ADC Therapeutics SA

ADCT

2.72

-3.55%

ADC Therapeutics shares are trading higher after Guggenheim initiated coverage on the stock with a Buy rating and announced a price target of $11.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via